The effect of N-acetylcysteine on Clara cells and Clara cell 16 kDa protein in a murine model of allergen-induced airway inflammation

Respirology

Volumn 10, Issue 2, 2005, Pages 157-163

  Nie, Xiaomeng ^a   Li, Qiang ^a   Cai, Gang ^a   Dai, Yimin ^a   Zhang, Jun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Allergen induced airway inflammation; Clara cell; Clara cell 16 kDa protein; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; ALLERGEN; CLARA CELL PROTEIN; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHIOLE; BRONCHUS HYPERREACTIVITY; CELL SECRETION; CLARA CELL; CONTROLLED STUDY; EOSINOPHIL; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; LUNG LAVAGE; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; ANIMALS; BLOTTING, WESTERN; BRONCHI; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; UTEROGLOBIN;

EID: 18344364670     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2005.00698.x     Document Type: Article

References (30)

1. Umland TC, Swaminathan S, Furey W, Singh G, Pletcher J, Sax M. Refined structure of rat Clara cell 17kDa protein at 3.0 A resolution. J. Mol. Biol. 1992; 224: 441-8.
2. Bernard A, Dumont X, Roels H et al. The molecular mass and concentrations of protein 1 or Clara cell protein in biological fluids: a reappraisal. Clin. Chim. Acta 1993; 223: 189-91.
3. 2 activity. Life Sci. 1986; 38: 1813-19.
4. Lensmar C, Nord M, Gudmundsson GH et al. Decreased pulmonary levels of the anti-inflammatory Clara cell 16 kDa protein after induction of airway inflammation in asthmatics. Cell. Mol. Life Sci. 2000; 57: 976-81.
5. Arsalane K, Broechaert F, Knoops B, Wiedig M, Toubeau G, Bernard A. Clara cell specific protein (CC16) expression after acute lung inflammation induced by intratracheal lipopolysaccharide administration. Am. J. Respir. Crit. Care Med. 2000; 161: 1624-30.
6. Paredi P, Kharitonov SA, Barnes PJ. Analysis of expired air for oxidation products. Am. J. Respir. Crit. Care Med. 2002; 166: S31-7.
7. Henricks PAJ, Nijkamp FP. Reactive oxygen species as mediators in asthma. Pulm. Pharmacol. Ther. 2001; 14: 409-21.
8. Malm-Erjefalt M, Persson CG, Erjefalt JS. Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 2001; 24: 352-9.
9. Kung TT, Jones H, Adams GK 3rd et al. Characterization of a murine model of allergic pulmonary inflammation. Int. Arch. Allergy Immunol. 1994; 105: 83-90.
10. Blesa S, Cortijo J, Martinez-Losa M et al. Effectiveness of oral N-acetylcysteine in a rat experimental model of asthma. Pharmacol. Res. 2002; 45: 135-40.
11. To Y, Dohi M, Tanaka R, Sato A, Nakagome K, Yamamoto K. Early interleukin 4-dependent response can induce airway hyperreactivity before development of airway inflammation in a mouse model of asthma. Lab. Invest. 2001; 81: 1385-96.
12. Nilaver G, Kozlowski GP. Comparison of the PAP and ABC immunocytochemical techniques. In: Bullock GR, Petrusz P (eds). Techniques in Immunocytochemistry. Academic Press, London, 1989; 199-215.
13. Halatek T, Hermans C, Broeckaert F et al. Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur. Respir. J. 1998; 11: 726-33.
14. Elia J, Aoki A, Maldonado CA. Response of bronchiolar Clara cells induced by a domestic insecticide. Analysis of CC10 kDa protein content. Histochem. Cell Biol. 2000; 113: 125-33.
15. Hayward A. Who's to blame for asthma? Lancet 1995; 346: 1243.
16. Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N. Engl. J. Med. 1999; 340: 197-206.
17. Dierynck I, Bernard A, Roels H, De Ley M. The human Clara cell protein: biochemical and biological characterisation of a natural immunosuppressor. Mult. Scler. 1996; 1: 385-7.
18. Johnston CJ, Mango GW, Finkelstein JN, Stripp BR. Altered pulmonary response to hyperoxia in Clara cell secretory protein deficient mice. Am. J. Respir. Cell Mol. Biol. 1997; 17: 147-55.
19. Yao XL, Ikezono Z, Cowan M, Logun C, Angus CW, Shelhamer JH. Interferon-gamma stimulates human Clara cell secretory protein production by human airway epithelial cells. Am. J. Physiol. 1998; 274: L864-9.
20. Ramsay PL, Luo Z, Magdaleno SM et al. Transcriptional regulation of CCSP by interferon-gamma in vitro and in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 2003; 284: L108-18.
21. Harrod KS, Jaramillo RJ. Pseudomonas aeruginosa and tumor necrosis factor-alpha attenuate Clara cell secretory protein promoter function. Am. J. Respir. Cell Mol. Biol. 2002; 26: 216-23.
22. Ohkawara Y, Lei XF, Stampfli MR, Marshall JS, Xing Z, Jordana M. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airway inflammation. Am. J. Respir. Cell Mol. Biol. 1997; 16: 510-20.
23. Ventresca GP, Cicchetti V, Ferrari V. Acetylcysteine. In: Braga PC, Allegra L (eds). Drugs in Bronchial Mucology. Raven Press Ltd, New York, 1989; 77-102.
24. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic. Biol. Med. 1989; 6: 593-7.
25. Cotgreave IA. N-Acetylcysteine: pharmacological considerations and experimental and clinical applications. In: Sies H (ed). Antioxidants in Disease: Mechanisms and Therapy (Advances in Pharmacology, Vol. 38). Academic Press, New York, 1997; 205-27.
26. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N. Engl. J. Med. 2000; 343: 180-4.
27. Barnes PJ. Reactive oxygen species in asthma. Eur. Respir. Rev. 2000; 10: 240-3.
28. Ho E, Chen G, Bray TM. Supplementation of N-acetylcysteine inhibits NF-κ activation and protects against alloxan-induced diabetes in CD-1 mice. FASEB J. 1999; 13: 1845-54.
29. Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW. In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation. J. Immunol. 1996; 157: 1630-7.
30. Liu SF, Haddad EB, Adcock I et al. Inducible nitric oxide synthase after sensitization and allergen challenge of Brown Norway rat lung. Br. J. Pharmacol. 1997; 121: 1241-6.